These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1017202)

  • 41. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 42. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitation of the estrogenic effects of mestranol on human endometrium and vaginal mucosa.
    Henzl MR; Moyer DL; Townsend D; Valand RS; Segre EJ
    Am J Obstet Gynecol; 1973 Feb; 115(3):401-6. PubMed ID: 4682831
    [No Abstract]   [Full Text] [Related]  

  • 44. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium.
    Kreitmann B; Bugat R; Bayard F
    J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oral contraceptives on haemoglobin, packed-cell volume, serum-iron, and total iron-binding capacity in healthy women.
    Burton JL
    Lancet; 1967 May; 1(7497):978-80. PubMed ID: 4164605
    [No Abstract]   [Full Text] [Related]  

  • 46. Sequential approach to oral contraceptive therapy.
    Balin H; Wan LS; Rajan R
    Int J Fertil; 1969; 14(4):300-8. PubMed ID: 4186408
    [No Abstract]   [Full Text] [Related]  

  • 47. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
    Moore DE; Kawagoe S; Davajan V; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1978 Feb; 130(4):482-6. PubMed ID: 204191
    [No Abstract]   [Full Text] [Related]  

  • 48. Renin-renin substrate kinetic constants in the plasma of normal and estrogen-treated humans.
    McDonald WJ; Cohen EL; Lucas CP; Conn JW
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1297-304. PubMed ID: 591623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1977 Nov; 28(11):1182-90. PubMed ID: 411689
    [No Abstract]   [Full Text] [Related]  

  • 51. Control of ovulation time with steroid and nonsteroid compounds.
    Boutselis JG; Dickey RP; Vorys N
    Am J Obstet Gynecol; 1972 Jan; 112(2):171-7. PubMed ID: 4333405
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of oral contraceptives on the thromboelastogram.
    Fisch IR; Freedman SH; Pellegrin FA
    Clin Pharmacol Ther; 1973; 14(2):238-44. PubMed ID: 4695383
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of prenatal treatment with ethinyl estradiol on the mouse uterus and ovary.
    Yasuda Y; Kihara T; Nishimura H
    Am J Obstet Gynecol; 1977 Apr; 127(8):832-6. PubMed ID: 851139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

  • 57. OVULATION INHIBITORS: LARGE-SCALE CLINICAL TRIALS.
    MEARS E
    Int J Fertil; 1964; 9():1-9. PubMed ID: 14106258
    [No Abstract]   [Full Text] [Related]  

  • 58. [Sequential therapy].
    Annee Endocrinol; 1967; 19():97-102. PubMed ID: 4173491
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of oral contraceptives on lactation.
    Borglin NE; Sandholm LE
    Fertil Steril; 1971 Jan; 22(1):39-41. PubMed ID: 5099595
    [No Abstract]   [Full Text] [Related]  

  • 60. Depression of physical activity by contraceptive pills.
    Morris NM; Udry JR
    Am J Obstet Gynecol; 1969 Aug; 104(7):1012-4. PubMed ID: 4183357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.